Life Sciences Patents
Wearable Health Monitoring Patents
CGM, PPG, ECG, HRV, and sweat biosensor IP; wearable health monitoring patent landscape for digital health startups.
FAQ
Who are the major wearable health monitoring patent holders and what innovations do Abbott, Dexcom, and Apple protect?
Wearable health monitoring patents cover electrochemical biosensor and enzyme immobilization innovations; optical PPG photoplethysmography and pulse oximetry innovations; ECG single-lead AFib detection algorithm innovations; and heart rate variability HRV recovery scoring algorithm innovations — with IP held by medical device companies, consumer electronics companies, and digital health startups: MAJOR WEARABLE HEALTH MONITORING PATENT HOLDERS: ABBOTT: 1,000+; specific Libre innovations (specific specific FreeStyle Libre 3: specific specific 14-day subcutaneous glucose sensor from specific specific enzyme glucose oxidase GOx amperometric from specific specific Fano working electrode Ag/AgCl counter from specific specific polymer outer membrane PU PVC from specific specific ±10% MARD mean absolute relative difference from specific specific 5-minute reading interval from specific specific 25°C operating from specific specific factory calibrated no fingerstick from specific specific NFC ISO 15693 13.56 MHz wireless from specific specific 0.4 mm diameter sensor needle from specific specific 4.3 mm insertion depth from specific specific LibreLinkUp shared monitoring from specific specific Libre 2 real-time Bluetooth from specific specific Libre 3 smallest sensor 7.7 mm dia from specific specific sensor wear arm from specific specific low glucose alarm 70 mg/dL); DEXCOM: 500+; specific G7 innovations (specific specific Dexcom G7: specific specific 10-day sensor 60 min warmup from specific specific GOx membrane factory calibration from specific specific MARD 8.2% vs. 9.1% G6 from specific specific back-of-arm abdominal from specific specific direct-to-Apple Watch display from specific specific Bluetooth 5.0 low energy from specific specific smartphone-less direct display from specific specific Stelo OTC non-insulin 15-day from specific specific share follow 10 followers from specific specific G7 smallest CGM 60% smaller vs. G6); APPLE: 2,000+; WHOOP: 200+; GARMIN: 500+; OURA RING: 200+.
What PPG optical heart rate, SpO2 pulse oximetry, and ECG algorithm innovations are patentable?
Multi-wavelength LED photodetector PPG optical sensor design innovations; motion artifact cancellation and ambient light rejection algorithm innovations; and electrical ECG single-lead AFib classification deep learning innovations represent core wearable health monitoring patent domains: PPG AND OPTICAL PATENTS: APPLE; GARMIN; SAMSUNG; FITBIT/GOOGLE: specific PPG innovations (specific specific Apple Watch Elevate PPG: specific specific 4 infrared LED 4 green LED 2 red LED from specific specific 4 photodiode PD array from specific specific 6 electrode capacity from specific specific Green 525 nm HR absorption peak from specific specific IR 940 nm SpO2 from specific specific Red 660 nm SpO2 from specific specific PPG signal: specific specific AC/DC ratio from specific specific AC component 0.5-1 Hz pulse from specific specific DC baseline absorption from specific specific noise floor <1 nA from specific specific motion artifact: specific specific MEMS accelerometer 3-axis 100 Hz from specific specific adaptive filtering LMS from specific specific NLMS algorithm weights update from specific specific SpO2 pulse oximetry: specific specific Red/IR ratio R calibration empirical from specific specific Severinghaus curve 94-100% ± 2% accuracy from specific specific Apple Watch S9 blood oxygen 93-100% from specific specific AFib detection: specific specific 30-second window 600 Hz sampling from specific specific CNN classification afib/normal from specific specific ECG lead I wrist-to-wrist from specific specific PPG afib irregular R-R from specific specific De Novo FDA 2018 Apple Watch series 4 from specific specific 99.3% specificity 98.5% sensitivity); ECG PATENTS: APPLE; KARDIA; WITHINGS; PHILIPS: specific ECG innovations (specific specific single-lead ECG: specific specific lead I wrist-to-finger from specific specific lead II on-demand pulse from specific specific AFib classification DNN from specific specific QRS detection Pan-Tompkins from specific specific RR interval variability from specific specific AliveCor KardiaMobile: specific specific 6-lead handheld from specific specific FDA De Novo 2017 AFib from specific specific atrial fibrillation flutter from specific specific SVPB ventricular ectopy from specific specific normal sinus rhythm from specific specific Withings ScanWatch: specific specific 30-sec continuous ECG from specific specific passive PPG irregular detection from specific specific Samsung Galaxy Watch: specific specific BioActive Sensor ECG + PPG + BIA from specific specific 5 GHz skin impedance); SWEAT AND ELECTROCHEMICAL PATENTS: ECCRINE; PROFUSA; L-NUTRACEUTIX: specific electrochemical innovations (specific specific sweat glucose lactate: specific specific PDMS microfluidic sweat channel from specific specific enzymatic amperometric GOx LOx from specific specific chronoamperometry square wave from specific specific PEDOT:PSS hydrogel electrode from specific specific glucose 50-150 μM sweat range from specific specific lactate 4-20 mM exercise from specific specific cortisol: specific specific cortisol antibody lateral flow from specific specific LOD 1 ng/mL from specific specific electrolyte sodium potassium: specific specific ion selective electrode ISE from specific specific Na⁺ K⁺ Cl⁻ from specific specific Eccrine Systems Q-Sport from specific specific Profusa tissue-integrating biosensor: specific specific polymer hydrogel implant from specific specific continuous glucose 6 months from specific specific fluorescence reporter bead from specific specific CMOS imager wearable receiver).
What HRV, continuous temperature, bioimpedance, and multi-sensor fusion innovations are patentable in wearables?
Heart rate variability HRV RMSSD SDNN time-domain and frequency-domain algorithm innovations; skin temperature continuous monitoring thermistor and infrared innovations; and bioimpedance spectroscopy BIS body composition and fluid status innovations represent additional wearable health patent domains: HRV AND RECOVERY PATENTS: WHOOP; GARMIN; POLAR; BIOSTRAP: specific HRV innovations (specific specific RMSSD: specific specific root mean square successive differences from specific specific 64 Hz PPG sampling from specific specific NN intervals beat-to-beat from specific specific Whoop Recovery: specific specific HRV RMSSD baseline 7-day from specific specific resting HR from specific specific sleep performance from specific specific composite Recovery 0-100 from specific specific red <33 yellow 34-66 green 67+ from specific specific HRV SDNN: specific specific standard deviation NN intervals from specific specific frequency domain LF HF ratio sympathovagal from specific specific spectral 0.04-0.4 Hz LF from specific specific 0.15-0.4 Hz HF parasympathetic from specific specific pNN50 from specific specific Kubios analysis from specific specific strain score: specific specific Whoop 0-21 exertion from specific specific cardiovascular load sum of HR from specific specific recovery readiness from specific specific Polar Vantage V3 Firstbeat HRV4Training from specific specific Garmin Body Battery from specific specific EPOC excess post-exercise oxygen consumption); TEMPERATURE PATENTS: OURA; TEMPDROP; APPLE; GOOGLE: specific temperature innovations (specific specific NTC thermistor: specific specific negative temperature coefficient 1% accuracy from specific specific skin temperature wrist finger from specific specific menstrual cycle tracking ±0.1°C from specific specific Oura ring infrared fingertip: specific specific 3.6 mm ring form factor from specific specific PPG + NTC + accelerometer + gyro from specific specific 24 hr continuous 0.1°C from specific specific predictive skin temp PST 0.2°C from specific specific TempDrop axillary 7-day from specific specific Apple Watch Series 9 wrist temperature from specific specific night temperature cycle detection); BIOIMPEDANCE PATENTS: SAMSUNG; WITHINGS; IMPEDIMED: specific BIA innovations (specific specific BIA bioelectrical impedance: specific specific 50 kHz single frequency from specific specific multi-frequency MF-BIA 5-500 kHz from specific specific body composition fat mass from specific specific Total body water TBW FFM from specific specific Samsung BioActive Sensor 5 GHz from specific specific Withings Body Comp EDA from specific specific ImpediMed lymphedema 256 frequency from specific specific InBody 720 8-electrode segmental from specific specific chest fluid status: specific specific congestion index impedance cardiography IC from specific specific fluid overload 500 mL sensitivity from specific specific wearable patch 4-electrode thoracic from specific specific SENSOR FUSION: specific specific multi-modal fusion: specific specific Kalman filter state estimation from specific specific IMU accelerometer gyroscope from specific specific baroaltimeter elevation from specific specific GPS GNSS outdoor exercise from specific specific ECG+PPG+BIA Samsung from specific specific ML prediction: specific specific XGBoost VO₂max from specific specific LSTM sleep staging W1R2N3 from specific specific CNN arrhythmia classifier from specific specific feature engineering RR interval HRV FFT).
What IP strategy should wearable biosensor and digital health startup founders use?
Wearable health startup IP strategy must navigate Abbott FreeStyle Libre CGM patents (1,000+), Dexcom G7 CGM patents (500+), Apple Watch PPG SpO2 and ECG AFib patents (2,000+), Whoop HRV recovery scoring patents (200+), and Garmin PPG motion artifact patents (500+); understand that Abbott and Dexcom hold the dominant CGM electrochemical enzyme biosensor IP and Apple holds broad PPG multi-wavelength and ECG AFib classification IP; identify whitespace in novel non-invasive glucose sensing (NIR spectroscopy, Raman, microwave), novel sweat metabolite multiplexed sensing (glucose, lactate, cortisol, uric acid, electrolytes), novel continuous blood pressure cuff-less PTT/PWA innovations, and novel multi-modal sensor fusion for health score composite — while understanding that the global wearable medical device market exceeds $25B and FDA De Novo and 510(k) pathways drive strong first-mover IP advantages for novel wearable biosensors: WEARABLE HEALTH STARTUP IP STRATEGY: UNDERSTAND THE WEARABLE HEALTH PATENT LANDSCAPE — ABBOTT AND DEXCOM HOLD BROAD CGM ENZYME SENSOR IP AND APPLE HOLDS BROAD PPG/ECG IP: Abbott FreeStyle Libre GOx enzyme amperometric factory-calibrated subcutaneous sensor patents and Dexcom G7 10-day MARD 8.2% sensor patents cover the dominant CGM platform — new CGM entrants need novel enzyme immobilization (multi-enzyme cascade glucose ↔ H₂O₂ ↔ mediator), novel polymer membrane, or non-enzymatic electrochemical glucose detection; NOVEL NON-INVASIVE GLUCOSE AND NOVEL SWEAT METABOLITE MULTIPLEX ARE HIGHEST-VALUE LEAST-CONSOLIDATED IP: After Apple Watch series 9 launched near-infrared non-invasive glucose speculation (unconfirmed) and Eccrine Systems Q-Sport sweat lactate-glucose launch, novel NIR 1,600-1,800 nm glucose Raman shift with novel calibration and novel multiplexed sweat patch represent less consolidated patent territory; NOVEL CUFF-LESS CONTINUOUS BLOOD PRESSURE PTT PULSE TRANSIT TIME AND PWA PULSE WAVE ANALYSIS ARE PATENT-VIABLE: Samsung and Valencell hold broad PTT cuff-less BP patents; novel oscillometric multi-point calibration algorithm, novel peripheral vascular compliance model, or novel combined ECG+PPG pulse transit time <1 ms latency with novel drift correction represent patentable innovations toward FDA-cleared continuous BP; WHEN TO PATENT IN WEARABLE HEALTH MONITORING: NOVEL SENSOR WITH MEASURED CLINICAL ACCURACY AND ANALYTE RANGE: specific novel wearable biosensor (specific specific analyte + specific specific sensing modality + specific specific MARD % or accuracy ± + specific specific measurement interval + specific specific wear time days + specific specific calibration requirement) vs. specific Abbott Libre 3 GOx MARD ±10% 5min 14-day factory calibrated or specific Dexcom G7 MARD 8.2% 10-day factory calibrated or specific Apple Watch AFib 99.3% specificity 98.5% sensitivity baseline — measured MARD %, specificity, sensitivity, and wear time vs. Abbott, Dexcom, or Apple Watch baseline is the critical wearable health IP metric; KEY FTO CHECKLIST: Abbott FreeStyle Libre 3 GOx amperometric ±10% MARD 5min 14-day NFC ISO 15693 factory calibrated 0.4mm 4.3mm; Dexcom G7 GOx MARD 8.2% 10-day BT 5.0 factory back-of-arm; Apple Watch Series 9 4-LED 4-PD SpO2 PPG 6 electrode ECG lead I AFib 600Hz CNN 99.3%; Whoop 64 Hz HRV RMSSD recovery 0-100; Garmin Elevate v5 4-PD NLMS motion artifact; Oura ring NTC 0.1°C 3.6mm; Samsung BioActive ECG+PPG+BIA 5 GHz; Eccrine Q-Sport sweat glucose lactate GOx PEDOT:PSS microfluidic PDMS; Profusa hydrogel 6-month fluorescence.
Related Guides